Navigation Links
Genomatix gets patent for comparative genomics method
Date:3/12/2009

Genomatix Software, a company with an outstanding track record in the analysis of genomic data generated by high throughput technologies, announced today that it was issued patent No. EP 1 800 232 B1, "Identification and assignment of functionally corresponding regulatory sequences for orthologous loci in eukaryotic genomes" by the European Patent Office.

The Patent relates to a sophisticated method for identification of networks of functionally related regulatory DNA sequences in different eukaryotic species. With today's high throughput sequencing technology data from an increasing number of various organisms become available. However, the genomic sequence does not reveal scientific insight in the functional organization of the genome. For such the genome needs to be annotated (e.g. location of genes, promoters, genomic repeats etc.). Annotation of regulatory sequences like promoters and enhancers is a special challenge which is not satisfactory solved until today. The patent describes a method using a defined transcriptional start side from a well annotated genome (like human) as an anchor to identify corresponding regulatory regions in the orthologuous areas of less defined species. Results have been proven to be of extremely high quality. Genomatix applies this method in its genomic database ElDorado since several years now and numerous such predicted promoters have been verified experimentally in the meantime.

Dr. Andreas Klingenhoff, Genomatix Head of Genomics and Annotation and the inventor of the approach says: "We developed the method over several years, running many projects aimed to identify the evolutionary conserved regulatory elements shared between different eucaryots. It was essential in understanding regulatory networks, mechanisms and pathways, including disease mechanisms in humans. With increasing insight into the extreme complexity of the transcriptome, the method becomes more and more valuable. We continuously work on further improvements and apply it to an increasing number of species, especially in light with our efforts in next generation sequencing data analysis."


'/>"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Related biology news :

1. CRG buys Genomatix Next Generation Sequencing analysis solution
2. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
3. Genomatix joins Illumina-Connect program
4. Pfizer inks global license to Genomatix Software and databases
5. NIA uses Genomatix in stem cell research, suggests novel transcription factors for stemness
6. BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use
7. BIO-key(R) Granted Additional Patent for Biometric Security Solution
8. LSUHSC awarded patent for compound inhibiting cancer and other diseases
9. Kount Receives Patent for Device Fingerprinting
10. Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
11. Scripps Research Institute awarded patent for remarkable chemical technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
Breaking Biology Technology: